BackSinopharm Group Ltd. Overview

Sinopharm Group Ltd. Accounts Payable

Track Sinopharm Group Ltd.'s accounts payable ($120B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$118.30B
↓ 22.51% YoYΔ $-34.37B vs prior year quarter

Peer trimmed avg / median

Loading

Sinopharm Group Ltd. Accounts Payable History

Loading

Sinopharm Group Ltd. vs. peers: Accounts Payable Comparison

Loading

Sinopharm Group Ltd. Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Sinopharm Group Ltd. (SHTDF) FAQ

As of the most recent data (June 2026), SHTDF shows a accounts payable of $120B. That compares with $150B in the prior-year period — down 22.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SHTDF's accounts payable is now $120B (was $150B) — a 22.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Sinopharm Group Ltd. is outperforming or lagging.

Tracking SHTDF's accounts payable over time shows whether Sinopharm Group Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $120B That compares with $150B in the prior-year period — down 22.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Sinopharm Group Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $120B) with ownership activity and broader fundamentals.